• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mucosal Immunol . Severity of neonatal influenza infection is driven by type I interferon and oxidative stress

tetano

Editor, Senior Moderator
Mucosal Immunol


. 2022 Nov 9.
doi: 10.1038/s41385-022-00576-x. Online ahead of print.
Severity of neonatal influenza infection is driven by type I interferon and oxidative stress


Ogan K Kumova[SUP] 1 2 [/SUP], Ioanna-Evdokia Galani[SUP] 3 [/SUP], Abhishek Rao[SUP] 1 [/SUP], Hannah Johnson[SUP] 4 [/SUP], Vasiliki Triantafyllia[SUP] 3 [/SUP], Stephanie M Matt[SUP] 4 [/SUP], Judy Pascasio[SUP] 5 [/SUP], Peter J Gaskill[SUP] 4 [/SUP], Evangelos Andreakos[SUP] 3 [/SUP], Peter D Katsikis[SUP] 6 [/SUP], Alison J Carey[SUP] 7 8 [/SUP]



Affiliations

Abstract

Neonates exhibit increased susceptibility to respiratory viral infections, attributed to inflammation at the developing pulmonary air-blood interface. IFN I are antiviral cytokines critical to control viral replication, but also promote inflammation. Previously, we established a neonatal murine influenza virus (IV) model, which demonstrates increased mortality. Here, we sought to determine the role of IFN I in this increased mortality. We found that three-day-old IFNAR-deficient mice are highly protected from IV-induced mortality. In addition, exposure to IFNβ 24 h post IV infection accelerated death in WT neonatal animals but did not impact adult mortality. In contrast, IFN IIIs are protective to neonatal mice. IFNβ induced an oxidative stress imbalance specifically in primary neonatal IV-infected pulmonary type II epithelial cells (TIIEC), not in adult TIIECs. Moreover, neonates did not have an infection-induced increase in antioxidants, including a key antioxidant, superoxide dismutase 3, as compared to adults. Importantly, antioxidant treatment rescued IV-infected neonatal mice, but had no impact on adult morbidity. We propose that IFN I exacerbate an oxidative stress imbalance in the neonate because of IFN I-induced pulmonary TIIEC ROS production coupled with developmentally regulated, defective antioxidant production in response to IV infection. This age-specific imbalance contributes to mortality after respiratory infections in this vulnerable population.
 
Back
Top Bottom